Obesity GEM Forum - Behavioral and/or Pharmacological Treatment of Obesity: Which Is It?

Chair(s)

• NG

  Nana Gletsu-Miller, PhD (she/her/hers)

  Associate Professor
  Indiana University
  Bloomington, Indiana, United States

  Disclosure(s): Center for Responsible Nutrition: Advisory Committee/Board Member (Ongoing)
  Eli Lilly and Co.: Grant/Research Support (Ongoing)
  Haleon: Advisory Committee/Board Member (Ongoing)
  Hass avocado Board: Grant/Research Support (Ongoing)
• 

  Drew Sayer, PhD (he/him/his)

  Assistant Professor
  Department of Family and Community Medicine
  The University of Alabama at Birmingham
  Birmingham, Alabama, United States

  Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.

Speaker(s)

• KB

  Ksenia Blinnikova, MD, MPH

  Physician
  The University of Alabama at Birmingham
  Boston, Massachusetts, United States

  Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.
• 

  Nikhil Dhurandhar, LCEH, MS. PhD, FTOS (he/him/his)

  Professor and Department Chair
  Texas Tech University
  Lubbock, Texas, United States

  Disclosure(s): Borealis Foods: Grant/Research Support (Ongoing)
  Indiana University Foundation: Grant/Research Support (Ongoing)
  Insparin Therapeutics: Grant/Research Support (Ongoing); Ownership Interest (Ongoing)
  International Egg Commission: Advisory Committee/Board Member (Ongoing)
  Medifast, Inc.: Advisory Committee/Board Member (Ongoing)
  National Cattleman's Beef Association: Grant/Research Support (Terminated)
  Novo Nordisk: Grant/Research Support (Terminated)
  Obthera / Metabologix: Consultant (Ongoing)
  Springer Nature: Advisory Committee/Board Member (Ongoing)
• 

  Leah Whigham, PhD (she/her/hers)

  Center Director and Associate Professor
  University of Texas Health Science Center at Houston (UTHealth Houston)
  El Paso, Texas, United States

  Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.

Recently approved and anticipated medications for obesity treatment are producing much greater and more durable weight loss than previous behavioral and pharmacological approaches. Many patients are reporting dramatic reductions in appetite, hunger, and food cravings that enable sustained energy restriction and substantial weight loss. Given the effectiveness of these medications, many in the obesity research and treatment field are left wondering what – if any – role nutrition and other lifestyle-based interventions may have in this “new era” of obesity treatment. Please join the Obesity RIS Forum as we discuss this important topic with Dr. Ksenia Blinnikova, a practicing family medicine physician who regularly treats patients with obesity, Dr. Leah Whigham, Associate Professor and Director of the Center for Community Health Impact at The University of Texas Health Science Center at Houston School of Public Health, El Paso Campus, and Dr. Nikhil Dhurandhar, Professor, Helen Devitt Jones Endowed Chair, and Chair of the Department of Nutritional Sciences at Texas Tech University.